Standard chronic immunosuppression after kidney transplantation for systemic lupus erythematosus eliminates recurrence of disease

Clinical Transplantation

Volumn 19, Issue 1, 2005, Pages 56-60

  Dong, Guanglong ^a   Panaro, Fabrizio ^a   Bogetti, Diego ^a   Sammartino, Cinzia ^a   Rondelli, Damiano ^a   Sankary, Howard ^a   Testa, Giuliano ^a   Benedetti, Enrico ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Calcineurin inhibitors; Kidney transplantation; Systemic lupus erythematosus

Indexed keywords

BASILIXIMAB; CALCINEURIN INHIBITOR; CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PREDNISONE; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DISEASE ACTIVITY; DRUG DOSE REGIMEN; DRUG EFFICACY; FEMALE; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LONG TERM CARE; MALE; PRIORITY JOURNAL; RECURRENT DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; CALCINEURIN; CYCLOSPORINE; FEMALE; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; MALE; MIDDLE AGED; RECURRENCE; SEVERITY OF ILLNESS INDEX; TACROLIMUS;

EID: 13644258662     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2004.00297.x     Document Type: Article

References (24)

1. Thervet E, Anglicheau D, Legendre C. Recent issues concerning renal transplantation in systemic lupus erythematosis patients. Nephrol dial Transplant 2001: 16: 12.
2. Mojcik CF, Klippel JH. End-stage renal disease and systemic lupus erythematosus. Am J Med 1996: 101: 100.
3. Gipson DS, Ferris ME, Dooley MA, Huang K, Hogan SL. Renal transplantation in children with lupus nephritis. Am J Kidney Dis 2003: 41: 455.
4. Bumgardner GL, Mauer SM, Payne W et al. Single-center 1-15-year results of renal transplantation in patients with systemic lupus erythematosus. Transplantation 1988: 46: 703.
5. Goss JA, Cole BR, Jendrisak MD et al. Renal transplantation for systemic lupus erythematosus and recurrent lupus nephritis. A single-center experience and a review of the literature. Transplantation 1991: 52: 805.
6. Azevedo LS, Romao JE Jr., Malheiros D et al. Renal transplantation in systemic lupus erythematosus. A case control study of 45 patients. Nephrol Dial Transplant 1998: 13: 2894.
7. Stone JH, Millward CL, Olson JL et al. Frequency of recurrent lupus nephritis among ninety-seven renal transplant patients during the cyclosporine era. Arthritis Rheum 1998: 41: 678.
8. Kuiper-Geertsma DG, Derksen R. Newer drugs for the treatment of lupus nephritis. Drug 2003: 63: 167.
9. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982: 25: 1271.
10. Group T. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression in liver transplantation: the U.S. Multicenter FK506 Liver Study Group. N Engl J Med 1994: 331: 1110.
11. De Mattos AM, Olyaei AJ, Bennett WM. Nephrotoxicity of immunosuppressive drugs: long-term consequences and challenges for the future. Am J Kidney Dis 2000: 35: 333.
12. Bijl M, Horst G, Bootsma H et al. Mycophenolate mofetil prevents a clinical relapse in patients with systemic lupus erythematosus at risk. Ann Rheum Dis 2003: 62: 534.
13. Hariharan S, Peddi VR, Savin VJ et al. Recurrent and de novo renal diseases after renal transplantation: a report from the renal allograft disease registry. Am J Kidney Dis 1998: 31: 928.
14. Uchida H, Sugimoto H, Nishimura Y et al. Renal transplantation for systemic lupus erythematosus and recurrent lupus nephritis. Transplant Proc 1998: 30: 3908.
15. Ahuja TS, Boughton J, Weiss V et al. Lae recurrence of lupus nephritis in a renal transplant recipient: response to mycophenolate mofetil. Am J Med Sci 2001: 322: 166.
16. Stone JH, Amend WJ, Criswell LA. Outcome of renal transplantation in systemic lupus erythematosus. Semin Arthritis Rheum 1997: 27: 17.
17. Mathew TH. Recurrence of disease following renal transplantation. Am J Kidney Dis 1998: 12: 85.
18. Nyberg G, Blohme I, Persson H et al. Recurrence of SLE in transplanted kidneys: a follow-up transplant biopsy study. Nephrol dial Transplant 1992: 7: 1116.
19. Goral S, Ynares C, Shappell SB et al. Recurrent lupus nephritis in renal transplant recipients revisited: it is not rare. Transplantation Mar 2003: 75: 651.
20. Magee JC, Leichtman AB, Merion RM. Renal transplantation for systemic lupus erythematosis: excellent long-term results with both living and cadaveric donors. Transplant Proc 1998: 30: 1798.
21. Tsang WK, Tong KL, Tang HL et al. Thirteen-year results of renal transplantation in patients with systemic lupus erythematosus. Transplant Proc 2000: 32: 1824.
22. Van Bruggen MC, Walgreen B, Ruke TP et al. Attenuation of murine lupus nephritis by mycophenolate mofetil. J Am Soc Nephrol 1998: 9: 1407.
23. Dooley MA, Cosio FG, Nachman PH et al. J-9. Mycophenolate mofetil therapy in lupus nephritis: clinical observations. J Am Soc Nephrol 1999: 10: 833.
24. Lazarus AH, Ellis J, Semple JW et al. Comparison of platelet immunity in patients with SLE and with ITP. Transfus Sci 2000: 22: 19.